Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
D000082 |
Acetaminophen |
Acetaminophen affects the expression of DLG5 mRNA | affects expression | 17562736
|
D016047 |
Zalcitabine |
[gp120 protein, Human immunodeficiency virus 1 co-treated with Zalcitabine] results in increased expression of DLG5 mRNA | affects cotreatment|increases expression | 18606552
|
D011397 |
Promegestone |
methoxyacetic acid promotes the reaction [Promegestone results in increased expression of DLG5 mRNA] | increases expression|increases reaction | 15103026
|
D011397 |
Promegestone |
Promegestone results in increased expression of DLG5 mRNA | increases expression | 15103026
|
C514793 |
gp120 protein, Human immunodeficiency virus 1 |
[gp120 protein, Human immunodeficiency virus 1 co-treated with Zalcitabine] results in increased expression of DLG5 mRNA | affects cotreatment|increases expression | 18606552
|
C013598 |
methoxyacetic acid |
methoxyacetic acid promotes the reaction [Promegestone results in increased expression of DLG5 mRNA] | increases expression|increases reaction | 15103026
|
D015741 |
Metribolone |
Metribolone results in increased expression of DLG5 mRNA | increases expression | 17010196
|
C006253 |
pirinixic acid |
[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of DLG5 mRNA | affects binding|increases activity|increases expression | 19710929
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of DLG5 mRNA | increases expression | 19465110
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
methoxyacetic acid |
9.96 | 1761407 1761404 3652986 15959878 12805644 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
9.96 | 11752688 15322242 14514962 |
MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
3.38 | 18653653 |
MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
11.05 | 16434500 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
11.05 | 16835633 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
3.17 | 11748828 |
MESH:D000799 |
Angioedema |
|
Acetaminophen |
4.22 | 10982225 |
MESH:D001321 |
Autistic Disorder |
|
Acetaminophen |
1.40 | 18445737 |
MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
9.59 | 19483382 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
9.59 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
4.17 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.91 | 15746008 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
1.68 | 20435547 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.99 | 16835633 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Acetaminophen |
1.39 | 3084413 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.49 | 18850075 18670907 16120746 |
MESH:D009202 |
Cardiomyopathies |
|
Zalcitabine |
4.86 | 10591146 |
MESH:D002386 |
Cataract |
|
Acetaminophen |
2.71 | 10977129 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
3.38 | 16835633 |
MESH:D002779 |
Cholestasis |
|
pirinixic acid |
3.00 | 19176532 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
2.19 | 15668235 15340226 16354765 12621046 8697196 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
3.27 | 17141729 14669216 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
1.26 | 10048152 15322242 20055451 |
MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.52 | 18249437 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
1.71 | 17107852 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Acetaminophen |
3.75 | 16109766 19739265 17522070 11529661 14725611 10915739 12958197 11287661 11834606 14550746 12705907 12540782 10774834 11739529 16081117 16393943 11461765 19420014 18071297 10663392 15968718 12153990 11421492 11743745 17906064 12594235 19370779 12392966 17562736 19164858 19085960 15619225 16227642 16485898 19416960 19923254 14986274 18713872 16781746 2444490 16177239 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
3.75 | 20420201 |
MESH:D056487 |
Drug-Induced Liver Injury, Chronic |
|
Acetaminophen |
4.47 | 19426721 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
9.13 | 11462148 |
MESH:D004362 |
Drug Toxicity |
|
Zalcitabine |
9.13 | 7515130 |
MESH:D004487 |
Edema |
|
pirinixic acid |
7.35 | 12083418 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
7.35 | 12711302 11000095 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
4.28 | 15322242 16714409 18230668 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
3.25 | 10568697 9294722 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
3.19 | 11564622 |
MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
9.07 | 20131406 19236843 |
MESH:D005234 |
Fatty Liver |
|
Zalcitabine |
9.07 | 18299183 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.76 | 11858732 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
3.25 | 20067830 |
MESH:D005532 |
Foot Deformities, Congenital |
|
methoxyacetic acid |
6.00 | 3652986 |
MESH:D005756 |
Gastritis |
|
Acetaminophen |
4.05 | 16983495 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.97 | 10696789 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
2.44 | 11294989 10048152 |
MESH:D006333 |
Heart Failure |
|
pirinixic acid |
2.67 | 20558911 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.58 | 11000095 |
MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
9.30 | 16221962 18467677 19772884 19176532 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
9.30 | 16120746 12621046 15340226 |
MESH:D015658 |
HIV Infections |
|
Zalcitabine |
4.45 | 17457083 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
4.42 | 18606429 16959395 15340226 8697196 16354765 |
MESH:D006930 |
Hyperalgesia |
|
Acetaminophen |
2.89 | 16870215 |
MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
3.41 | 20558911 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
1.98 | 18670907 18850075 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
1.96 | 12200463 12878042 |
MESH:D015212 |
Inflammatory Bowel Diseases |
marker/mechanism |
|
| |
MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
2.78 | 16306350 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.58 | 16580747 |
MESH:D007674 |
Kidney Diseases |
|
Acetaminophen |
2.32 | 12587719 15629191 |
MESH:D017880 |
Limb Deformities, Congenital |
|
methoxyacetic acid |
4.90 | 12805644 15959878 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
2.19 | 15474484 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
2.19 | 12878042 |
MESH:D008107 |
Liver Diseases |
|
Acetaminophen |
1.67 | 12969438 11587558 19014921 16611625 19784758 12587719 19460945 16610002 |
MESH:D017114 |
Liver Failure, Acute |
|
Acetaminophen |
3.46 | 17185352 16871587 |
MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
4.51 | 20007298 16377806 15890375 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
4.51 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
2.24 | 12151625 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
1.24 | 11884234 19555203 |
MESH:D008223 |
Lymphoma |
|
Zalcitabine |
4.81 | 9205081 18798262 8840982 11980663 8764131 9488045 17941976 |
MESH:D008546 |
Melanoma, Experimental |
|
Acetaminophen |
3.87 | 19513568 |
MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
3.81 | 16239165 |
MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
2.22 | 19151258 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
3.21 | 12213967 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
3.13 | 16411023 |
MESH:D009369 |
Neoplasms |
|
pirinixic acid |
2.05 | 17405874 |
MESH:D009374 |
Neoplasms, Experimental |
|
Zalcitabine |
5.41 | 9205081 9488045 8764131 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
3.49 | 14600291 |
MESH:D009437 |
Neuralgia |
|
Zalcitabine |
6.65 | 17292584 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Acetaminophen |
3.07 | 18514411 |
MESH:D009765 |
Obesity |
|
pirinixic acid |
1.86 | 20558911 |
MESH:D010146 |
Pain |
|
Acetaminophen |
2.59 | 16870215 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.62 | 12520081 |
MESH:D010523 |
Peripheral Nervous System Diseases |
|
gp120 protein, Human immunodeficiency virus 1 |
11.89 | 18606552 |
MESH:D010523 |
Peripheral Nervous System Diseases |
|
Zalcitabine |
11.89 | 18606552 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.84 | 18163543 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
3.53 | 11118676 11399792 11896295 11222880 |
MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
2.49 | 19058328 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
4.12 | 18990726 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
2.14 | 16192470 |
MESH:D013576 |
Syndactyly |
|
methoxyacetic acid |
5.91 | 1761407 1761404 |
MESH:D013733 |
Testicular Diseases |
|
methoxyacetic acid |
5.67 | 18486176 6499806 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
4.28 | 12697716 |
MESH:D014581 |
Urticaria |
|
Acetaminophen |
3.24 | 10982225 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.97 | 12125929 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.62 | 15886252 |